Navigation Links
Breast Cancer Survivors Worry About Infertility

A new survey conducted by the Dana-Farber Cancer Institute shows more than half of young breast cancer survivors overestimated their risk for developing treatment-related infertility problems.//

Nearly 700 members of the advocacy organization Young Survival Coalition Group who were 40 years old or younger were surveyed. More than half of the respondents, or 57 percent, said they were concerned about being infertile as a result of cancer treatments they had undergone.

Past research has revealed that few women in this age group go through menopause because of standard treatment, and some studies even show a zero-percent incidence in patients.

Ann H. Partridge, M.D., says this study should serve as a wakeup call for health care providers.

"We don't have a great system for educating these women and showing them data -- even if incomplete -- about these questions and advising them on what they can consider to attempt to preserve fertility," says Dr. Partridge."[Women's] risk perceptions are likely grossly exaggerated; there is room for education here."

Doctors often assume infertility concerns are more prevalent in younger women with less-advanced stages of cancer. However, research shows that infertility is an issue for women who have a desire to bear children, regardless of age or cancer stage.

Dr. Partridge also says the effects of older treatments are fairly well known, but there is less information on the more modern ways of delivering chemotherapy.

The study was presented at the San Antonio Breast Cancer Symposium. Researchers say it is the largest study to date that addresses infertility and menopausal concerns among young women with breast cancer.


'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer

Post Your Comments:
(Date:11/27/2009)...alth™ announced today that Spectrum Health (... Enterprise orthopedic templating solution and its... (PRWEB) November 27, 2009 -- Voyant ... (Grand Rapids, Michigan) has licensed its TraumaC...ts TraumaCad Extend workflow solution, to allow it...
(Date:11/26/2009)...-Withcoldandfluseasonuponus,it,smoreimportantthane...ionsandavoidillness. ,, "Weneedtobeproactivenot...llnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(cer...tioncontrolandoccupationalhealthatHospitalforSpeci...lSurgeryhasoneofthelowestinfectionratesofanyhospit...
(Date:11/26/2009)... can lead to strains or worse , , THURSD...ng wrong with stuffing your turkey full to burstin...h your suitcase as you pack for holiday trips. ,...U.S. hospital emergency rooms, doctors, offices, c...lated injuries, such as muscle strains, pulls and ...
(Date:11/26/2009)...Triangle Dental (RTDental), a leading dental group...ed the expansion of its services to include LUMINE...illan. , Durham, NC (P...nounce that Dr. Doug Macmillan, an experienced LU... advanced training seminar. RTDental’s abil...
(Date:11/25/2009)...swire/--TheBartleHallConventionCenterwilltemporari...whenKansasCityhoststhelatestinaseriesofmassivefree...enthasthepotentialtobethebiggestoneyet,becauseitwi...daysinsteadofoveraweekend,"SheriWood,executivedire...heNationalAssociationofFreeClinics(NAFC). ,, At...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2
... addresses health disparities in children; adolesc...tion for Quality Healthcare announced today that i...ity Health Centers, Inc. (MCCHC) in Alexandria, I... children. , , The program focuses on conducting ...
...r Human Rights responds to the publication of a l...e Red Cross which concludes that health profession...et detention centers committed gross violations of... confidential International Committee of the Red C...
... ETS EXPOSURE , Environmental tobacco smoke (ETS) ...n children. However, a new study shows that reduci...iversity of Alabama researchers followed 240 child...ded to caregivers; however, children were given 20...
... of African American employees , , GAITHERSBURG,...xo, a leading integrated food and facilities manag...t who I am as an African American and a woman and ... African American Leadership Forum network group. ...
...he comScore, Inc. February rankings, Health Guru M... growing health site on the web over the last thre...o one of the few health sites with more video view...ruary rankings, Health Guru Media (HealthGuru.com)...
...lp facilitate dialogue,during an eye examination b...Hispanic patients, Transitions Optical has develop...his free bilingual guide illustrates key steps tha...n,critical to making the best possible recommendat...
Other Medicine News:Health News:Centene Foundation for Quality Healthcare Awards Grant to Community Health Center 2Health News:In Wake of ICRC Report, Health Professionals Must Be Held Accountable for Torture 2Health News:In Wake of ICRC Report, Health Professionals Must Be Held Accountable for Torture 3Health News:Journal Chest: April news briefs 2Health News:Sodexo Named as One of the Top Three Companies for African Americans on 2009 DiversityInc Top Ten Companies List 2Health News:Web's Fastest Growing Health Site is a Video Site 2Health News:Web's Fastest Growing Health Site is a Video Site 3Health News:Free Bilingual Eye Exam Guide Now Available to Eyecare Professionals 2Health News:Free Bilingual Eye Exam Guide Now Available to Eyecare Professionals 3
(Date:11/25/2009)...stCall/--ERT(Nasdaq: ERES ),announcedtodaythatDr.M...ithSchneck,theCompany,sExecutiveVicePresidentandCF...HealthCareConferenceat1:30PMESTonDecember1,2009inN...ssthepresentationbyvisitingtheCompany,scorporatewe...essedat http://www.corporate-ir.net/ireye/conflobb...
(Date:11/25/2009)...USNewswire/--RemediumTechnologiesInc.,acompanydeve...g,wonfirstprizeand$10,000intheMostPromisingSecurit...anyofficialsannouncetoday. ,, Selectedfrommoret...hedtheirinventionattheGSCSecuritySummitconferenceh...w.remediumtechnologies.com )isdevelopingahigh-pres...
(Date:11/25/2009)...linker.comannouncesthatanewmarketresearchreportisa...nt-AGlobalMarketPerspective ,, http://www.re...Global-Market-Perspective.html ,, Risingincide...gnationsisaprincipalfactorinfluencinggrowthinthema...reastcancerhasallowedwomentocomeforwardfortheiryea...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Extending treatment after liver transplant may benefit patients with hepatitis C recurrence 60452 1Extending treatment after liver transplant may benefit patients with hepatitis C recurrence 60452 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 1Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 1BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 2BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 4BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 5BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 6BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 7
...tro Assays Show rBChE Suppresses Amyloid Plaque,Fo...ene, Inc., a leading,biodefense company specializi...ical countermeasures against chemical and,biologic...ts,recombinant butyrylcholinesterase (rBChE) resea...ernational Conference on,Alzheimer,s and Parkinson...
...T, N.J., April 04, 2007 /PRNewswire-FirstCall/ -- ...perative Oncology Group,(ECOG) has reported that i...liminary results from a large, randomized clinical...myeloma has found,that the use of a low dose of de...omide suggests survival advantage for,patients whe...
Other Medicine Technology:Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 2ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 4ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 5ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 7
...BAK/C cervical interbody fusion system represents ...ive disc disease of the cervical spine. The system...ration, and implantation. The self-packing of bone...raft, eliminating the need to harvest from the ili...
Intera 3.0T
...The Intradiscal Instruments are designed to provid...sc removal, endplate preparation, and insertion of...tebral Spreaders, Intradiscal Wedges, Spanners, Ne...er. Used in ALIF (Anterior Thoracic Interbody Fusi...
...Symphony II Platelet Concentrate System is a point... of Platelet Concentrate (also referred to as Plat...PPP) from a small sample of blood. The Symphony II...s, which are found in the platelets. The platelet ...
Medicine Products: